retatrutide type 2 diabetes phase 2 trial results 2024 💉 may be redefining obesity treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Retatrutide vs Survodutide: 24% vs

What parts of the brain and what kinds of cells are involved is another important question that has not been fully addressed

In particular, greater understanding of the bidirectional interactions between the gut microbiota and the central nervous system via the MGBA may lead to more effective interventions

The demand is perpendicular to rising obesity and diabetes cases, with the 2025 World Obesity Atlas projecting that the total number of adults living with obesity will increase by around 115 percent by 2030

A more significant concern is the increased risk of hypoglycemia (low blood sugar), especially if other glucose-lowering medications are also being used

I Lost 30 Pounds and My Energy Skyrocketed Before TRT, just getting through the day was a chore for Amedee